Andrew J Freeman1, Eric A Youngstrom2, Jennifer K Youngstrom2, Robert L Findling3. 1. 1 Department of Psychology, University of Nevada , Las Vegas, Nevada. 2. 2 Department of Psychology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina. 3. 3 Bloomberg Children's Center, Division of Child and Adolescent Psychiatry, Johns Hopkins University , Baltimore, Maryland.
Abstract
OBJECTIVE: The revision of the Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5) added a new diagnosis of disruptive mood dysregulation disorder (DMDD) to depressive disorders. This study examines the prevalence, comorbidity, and correlates of the new disorder, with a particular focus on its overlap with oppositional defiant disorder (ODD), with which DMDD shares core symptoms. METHODS: Data were obtained from 597 youth 6-18 years of age who participated in a systematic assessment of symptoms offered to all intakes at a community mental health center (sample accrued from July 2003 to March 2008). Assessment included diagnostic, symptomatic, and functional measures. DMDD was diagnosed using a post-hoc definition from item-level ratings on the Schedule for Affective Disorders and Schizophrenia for School-Age Children that closely matches the DSM-5 definition. Caregivers rated youth on the Child Behavior Checklist. RESULTS: Approximately 31% of youth met the operational definition of DMDD, and 40% had Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) diagnoses of ODD. Youth with DMDD almost always had ODD (odds ratio [OR] = 53.84) and displayed higher rates of comorbidity with attention-deficit/hyperactivity disorder (ADHD) and conduct disorder than youth without DMDD. Caregivers of youth with DMDD reported more symptoms of aggressive behavior, rule-breaking, social problems, anxiety/depression, attention problems, and thought problems than all other youth without DMDD. Compared with youth with ODD, youth with DMDD were not significantly different in terms of categorical or dimensional approaches to comorbidity and impairment. CONCLUSIONS: The new diagnosis of DMDD might be common in community mental health clinics. Youth with DMDD displayed more severe symptoms and poorer functioning than youth without DMDD. However, DMDD almost entirely overlaps with ODD and youth with DMDD were not significantly different than youth with ODD. These findings raise concerns about the potentially confusing effects of using DMDD in clinical settings, particularly given that DSM-5 groups DMDD with depressive disorders, but ODD remains a disruptive behavior disorder, potentially changing the decision-making framework that clinicians use to select treatments.
OBJECTIVE: The revision of the Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5) added a new diagnosis of disruptive mood dysregulation disorder (DMDD) to depressive disorders. This study examines the prevalence, comorbidity, and correlates of the new disorder, with a particular focus on its overlap with oppositional defiant disorder (ODD), with which DMDD shares core symptoms. METHODS: Data were obtained from 597 youth 6-18 years of age who participated in a systematic assessment of symptoms offered to all intakes at a community mental health center (sample accrued from July 2003 to March 2008). Assessment included diagnostic, symptomatic, and functional measures. DMDD was diagnosed using a post-hoc definition from item-level ratings on the Schedule for Affective Disorders and Schizophrenia for School-Age Children that closely matches the DSM-5 definition. Caregivers rated youth on the Child Behavior Checklist. RESULTS: Approximately 31% of youth met the operational definition of DMDD, and 40% had Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) diagnoses of ODD. Youth with DMDD almost always had ODD (odds ratio [OR] = 53.84) and displayed higher rates of comorbidity with attention-deficit/hyperactivity disorder (ADHD) and conduct disorder than youth without DMDD. Caregivers of youth with DMDD reported more symptoms of aggressive behavior, rule-breaking, social problems, anxiety/depression, attention problems, and thought problems than all other youth without DMDD. Compared with youth with ODD, youth with DMDD were not significantly different in terms of categorical or dimensional approaches to comorbidity and impairment. CONCLUSIONS: The new diagnosis of DMDD might be common in community mental health clinics. Youth with DMDD displayed more severe symptoms and poorer functioning than youth without DMDD. However, DMDD almost entirely overlaps with ODD and youth with DMDD were not significantly different than youth with ODD. These findings raise concerns about the potentially confusing effects of using DMDD in clinical settings, particularly given that DSM-5 groups DMDD with depressive disorders, but ODD remains a disruptive behavior disorder, potentially changing the decision-making framework that clinicians use to select treatments.
Authors: Melissa A Brotman; Mariana Schmajuk; Brendan A Rich; Daniel P Dickstein; Amanda E Guyer; E Jane Costello; Helen L Egger; Adrian Angold; Daniel S Pine; Ellen Leibenluft Journal: Biol Psychiatry Date: 2006-11-01 Impact factor: 13.382
Authors: Christen M Deveney; Rebecca E Hommer; Elizabeth Reeves; Argyris Stringaris; Kendra E Hinton; Catherine T Haring; Pablo Vidal-Ribas; Kenneth Towbin; Melissa A Brotman; Ellen Leibenluft Journal: Depress Anxiety Date: 2014-12-12 Impact factor: 6.505
Authors: Nancy E Adleman; Stephen J Fromm; Varun Razdan; Reilly Kayser; Daniel P Dickstein; Melissa A Brotman; Daniel S Pine; Ellen Leibenluft Journal: J Child Psychol Psychiatry Date: 2012-06-01 Impact factor: 8.982
Authors: Darrel A Regier; William E Narrow; Diana E Clarke; Helena C Kraemer; S Janet Kuramoto; Emily A Kuhl; David J Kupfer Journal: Am J Psychiatry Date: 2013-01 Impact factor: 18.112
Authors: Simone P Haller; Katharina Kircanski; Argyris Stringaris; Michal Clayton; Hong Bui; Courtney Agorsor; Sofia I Cardenas; Kenneth E Towbin; Daniel S Pine; Ellen Leibenluft; Melissa A Brotman Journal: Behav Ther Date: 2019-11-27
Authors: Michael B First; Wolfgang Gaebel; Mario Maj; Dan J Stein; Cary S Kogan; John B Saunders; Vladimir B Poznyak; Oye Gureje; Roberto Lewis-Fernández; Andreas Maercker; Chris R Brewin; Marylene Cloitre; Angelica Claudino; Kathleen M Pike; Gillian Baird; David Skuse; Richard B Krueger; Peer Briken; Jeffrey D Burke; John E Lochman; Spencer C Evans; Douglas W Woods; Geoffrey M Reed Journal: World Psychiatry Date: 2021-02 Impact factor: 49.548
Authors: Lea R Dougherty; Chelsey S Barrios; Gabrielle A Carlson; Daniel N Klein Journal: J Child Adolesc Psychopharmacol Date: 2017-02-17 Impact factor: 2.576
Authors: Sarah E Martin; Jeffrey I Hunt; Lauren R Mernick; Mia DeMarco; Heather L Hunter; Maria Teresa Coutinho; John R Boekamp Journal: Child Psychiatry Hum Dev Date: 2017-06
Authors: Spencer C Evans; Michael C Roberts; Jared W Keeley; Tahilia J Rebello; Francisco de la Peña; John E Lochman; Jeffrey D Burke; Paula J Fite; Lourdes Ezpeleta; Walter Matthys; Eric A Youngstrom; Chihiro Matsumoto; Howard F Andrews; María Elena Medina-Mora; José L Ayuso-Mateos; Brigitte Khoury; Mayya Kulygina; Rebeca Robles; Pratap Sharan; Min Zhao; Geoffrey M Reed Journal: J Child Psychol Psychiatry Date: 2020-05-12 Impact factor: 8.982